Financial Ratios

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE496.252.95 (+0.6 %)
PREV CLOSE ( ) 493.30
OPEN PRICE ( ) 489.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11051
TODAY'S LOW / HIGH ( )486.25 499.00
52 WK LOW / HIGH ( )408.95 645
NSE495.002.65 (+0.54 %)
PREV CLOSE( ) 492.35
OPEN PRICE ( ) 490.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 104914
TODAY'S LOW / HIGH( ) 485.55 499.10
52 WK LOW / HIGH ( )409 645.75
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)16.5021.0627.6558.2337.00
   CEPS(Rs)21.6126.1832.7678.2654.13
   DPS(Rs)1.001.002.502.001.00
   Book NAV/Share(Rs)120.34104.9992.23266.86219.90
   Tax Rate(%)25.3923.6823.6922.4631.63
Margin Ratios
   Core EBITDA Margin(%)11.4514.2721.1215.1713.94
   EBIT Margin(%)9.6512.3718.9812.8911.60
   Pre Tax Margin(%)8.2011.3517.6410.708.78
   PAT Margin (%)6.128.6613.468.306.00
   Cash Profit Margin (%)8.0110.7715.9411.158.78
Performance Ratios
   ROA(%)7.2310.6216.599.546.49
   ROE(%)14.6521.2934.7923.7918.34
   ROCE(%)15.3820.8233.3521.2917.39
   Asset Turnover(x)1.181.231.231.151.08
   Sales/Fixed Asset(x)2.212.081.881.711.63
   Working Capital/Sales(x)4.825.384.376.047.75
Efficiency Ratios
   Fixed Capital/Sales(x)0.450.480.530.580.61
   Receivable days110.5698.5592.29100.60100.66
   Inventory Days70.5971.2566.5059.7360.46
   Payable days90.1788.8899.1296.7289.85
Valuation Parameters
   PER(x)20.4720.3725.132.174.33
   PCE(x)15.6316.3921.211.622.96
   Price/Book(x)2.814.097.530.470.73
   Yield(%)0.300.230.360.400.16
   EV/Net Sales(x)1.461.993.550.941.36
   EV/Core EBITDA(x)12.6913.7616.566.209.63
   EV/EBIT(x)15.1816.1018.717.3211.72
   EV/CE(x)1.672.204.151.562.00
   M Cap / Sales1.251.763.380.721.04
Growth Ratio
   Net Sales Growth(%)10.9617.5617.1212.4227.51
   Core EBITDA Growth(%)-11.55-20.6664.9721.3210.17
   EBIT Growth(%)-13.48-23.3572.4724.9613.55
   PAT Growth(%)-21.63-24.3389.9555.4918.86
   EPS Growth(%)-21.63-23.84-52.5157.3718.86
Financial Stability Ratios
   Total Debt/Equity(x)0.480.530.380.590.91
   Current Ratio(x)1.621.491.841.491.34
   Quick Ratio(x)1.050.921.090.930.93
   Interest Cover(x)6.6612.0814.135.904.11
   Total Debt/Mcap(x)0.170.130.050.310.31

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.